{"mainPropery":{"diseaseId":5622,"diseaseName":"Cerebrotendinous xanthomatosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5622/cerebrotendinous-xanthomatosis","synonyms":["CTX","Cerebral cholesterinosis","Sterol 27-hydroxylase deficiency"],"synonyms-with-source":[{"name":"CTX"},{"name":"Cerebral cholesterinosis"},{"name":"Sterol 27-hydroxylase deficiency","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"213700"},{"identifierType":"ORPHANET","identifierId":"909"},{"identifierType":"UMLS","identifierId":"C0238052"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":195,"resourceName":"United Leukodystrophy Foundation","abbreviation":"ULF","address1":"224 North Second Street","address2":"Suite 2","address3":"","address4":"","address5":"","city":"DeKalb","state":"IL","zip":"60115 ","country":"United States","phone":"+1-815-748-3211 ","tty":"","tollFree":"1-800-728-5483","fax":"+1-815-748-0844","email":"office@ulf.org","url":"https://ulf.org/","freeText":""},{"resourceID":917,"resourceName":"American Dietetic Association","address1":"120 South Riverside Plaza, Suite 2000","address2":"","address3":"","address4":"","city":"Chicago","state":"IL","zip":"60606-6995","country":"United States","phone":"","tollFree":"800-366-1655","fax":"","email":"knowledge@eatright.org","url":"http://www.eatright.org/Public/"},{"resourceID":2219,"resourceName":"Alex The Leukodystrophy Charity","abbreviation":"Alex TLC","address1":"45 Peckham High Street","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":"SE15 5EB","country":"United Kingdom","phone":" 020 7701 4388","tty":"","tollFree":"","fax":"","email":"info@alextlc.org","url":"https://www.alextlc.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/213700' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=213700' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Cerebrotendinous xanthomatosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Cerebrotendinous+xanthomatosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Cerebrotendinous xanthomatosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/cerebrotendinous-xanthomatosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Cerebrotendinous xanthomatosis. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":879,"resourceId":1585,"resourceName":"RDCRN - Steroid and Isoprenoid Research Consortium (STAIR)","descriptionText":"The <a href='https://www.rarediseasesnetwork.org/cms/stair/' target='_blank'>Sterol and Isoprenoid Diseases Consortium (STAIR)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The Steroid and Isoprenoid Research Consortium (STAIR) has a registry for patients who wish to be contacted about clinical research opportunities. <br /><br />For more information on the registry see: <a href='https://www.rarediseasesnetwork.org/cms/stair/Get-Involved/ContactRegistry' target='_blank'>https://www.rarediseasesnetwork.org/cms/stair/Get-Involved/ContactRegistry</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/leukodystrophies.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Leukodystrophy-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022690' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=909' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:213700' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2158,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"<a href='https://rarediseases.org/for-patients-and-families/help-access-medications/patient-assistance-programs-2/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has Disease-Specific Assistance Programs designed to help patients with out-of-pocket costs such as monthly insurance premiums or deductibles. In addition, some programs may provide financial assistance for additional expenses related to a patient's diagnosis such as travel to see a specialist.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":775,"questionText":"What is cerebrotendinous xanthomatosis?","answerText":"<strong>Cerebrotendinous xanthomatosis</strong> is a&nbsp;disorder characterized by abnormal storage of fats (lipids) in many areas of the body (<a href=\"http://www.ninds.nih.gov/disorders/lipid_storage_diseases/lipid_storage_diseases.htm\" target=\"_blank\">lipid storage disease</a>).[503] People with this disorder cannot break down certain lipids effectively (such as&nbsp;cholesterol), so these fats form fatty yellow nodules called xanthomas, that accumulate in the body,&nbsp;especially&nbsp;in the brain and the tendons that attach muscle to bone, which is reflected in the condition name (cerebro- meaning brain and -tendinous referring to tendons). Symptoms may include diarrhea, clouding of the lens of the eyes (cataracts), tendon problems and&nbsp;progressive neurologic problems, such as epilepsy, movement disorders, impaired speech (dysarthria), loss of sensation in the arms and legs (peripheral neuropathy), dementia, hallucinations, and depression. Other symptoms may include brittle bones that are prone to fracture (<a title=\"Show picture\" class=\"img-popup\" href=\"https://ghr.nlm.nih.gov/art/large/bone-with-osteoporosis.jpeg?ow\" data-footer=\"Credit: Tefi/Shutterstock.com\" data-remote=\"/art/large/bone-with-osteoporosis.jpeg\" data-alt=\"The inside of normal bone versus bone with osteoporosis. The bone with osteoporosis has larger empty spaces in the tissue.\" data-toggle=\"lightbox\" data-title=\"Osteoporosis\"><span class=\"nobreak\">osteoporosis<span title=\"Picture\"></span></span></a>) and an increased risk of developing heart or lung failure because of lipid buildup.[13737][503] It is caused by mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/CYP27A1\" target=\"_blank\">CYP27A1</a> </em>gene. Treatment may involve chenodeoxycholic acid (CDCA), inhibitors of HMG-CoA reductase, coenzyme Q<sub>10</sub> and surgery to remove cataracts.[503]<br />\r\n<br />\r\n<br />","dateModified":"2017-08-23T00:00:00"},"basicQuestions":[{"questionId":776,"questionText":"What are the signs and symptoms of cerebrotendinous xanthomatosis?","answerText":"The symptoms seen in cerebrotendinous xanthomatosis are listed below. We have also included the typical age when each symptom appears.[503]\r\n<ul>\r\n    <li>Chronic diarrhea (infancy)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/cataract.html\" target=\"_blank\">Cataracts</a> (early childhood)\r\n    </li>\r\n    <li>Mental impairment (infancy or at puberty)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001447.htm\" target=\"_blank\">Xanthomas</a> (adolescents to early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/dementia.html\" target=\"_blank\">Dementia</a> with slow deterioration in intellectual abilities (early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.ninds.nih.gov/disorders/spasticity/spasticity.htm\" target=\"_blank\">Spasticity</a> (early adulthood)\r\n    </li>\r\n    <li>Cerebellar signs such as <a href=\"http://www.nlm.nih.gov/medlineplus/tremor.html\" target=\"_blank\">intention tremor</a>, difficulty with fast hand movements, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003037.htm\" target=\"_blank\">nystagmus</a>, truncal <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=ataxia\" target=\"_blank\">ataxia</a>, and <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm\" target=\"_blank\">rhomberg's sign</a>) (early adulthood)\r\n    </li>\r\n    <li>Behavioral changes (early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003258.htm\" target=\"_blank\">Hallucinations</a> (early adulthood)\r\n    </li>\r\n    <li>Agitation (early adulthood)\r\n    </li>\r\n    <li>Aggression (early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/depression.html\" target=\"_blank\">Depression</a> (early adulthood)\r\n    </li>\r\n    <li>Suicide attempt (early adulthood)</li>\r\n</ul>\r\n<p>Other symptoms may include <a href=\"http://www.nlm.nih.gov/medlineplus/dystonia.html\" target=\"_blank\" style=\"font-size: 12pt;\">dystonia</a><span style=\"font-size: 12pt;\">, atypical parkinsonism, </span><a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=\"_blank\" style=\"font-size: 12pt;\">seizures</a><span style=\"font-size: 12pt;\">, and </span><a href=\"http://www.nlm.nih.gov/medlineplus/peripheralnervedisorders.html\" target=\"_blank\" style=\"font-size: 12pt;\">peripheral neuropathy</a><span style=\"font-size: 12pt;\">.</span></p>","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":779,"questionText":"What causes cerebrotendinous xanthomatosis?","answerText":"Cerebrotendinous xanthomatosis is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene/CYP27A1\" target=\"_blank\"><em>CYP27A1 </em>gene</a>.[503]","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12135,"questionText":"How is cerebrotendinous xanthomatosis inherited?","answerText":"Cerebrotendinous xanthomatosis is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;pattern.[13737]","dateModified":"2017-08-24T08:02:00","resourceClassificationName":"Inheritance","references":[{"referenceId":13737,"authors":"","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cerebrotendinous-xanthomatosis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":780,"questionText":"Is genetic testing available for cerebrotendinous xanthomatosis?","answerText":"Yes, testing of the <i>CYP27A1 </i>gene is available. The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0238052/\" target=_blank>Genetic Testing Registry</a> provides information on clinical and research tests available for this condition.","dateModified":"2013-09-12T16:53:00","resourceClassificationName":"Diagnosis","references":[]},{"questionId":778,"questionText":"How is cerebrotendinous xanthomatosis diagnosed?","answerText":"Cerebrotendinous xanthomatosis is diagnosed by a combination of clinical features,&nbsp;cholestanol levels, and genetic testing. People with cerebrotendinous xanthomatosis have high levels of cholestanol in their blood. Genetic testing of the CYP27A1 gene is also available and can detect mutations in about 98% of patients.[503]","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":781,"questionText":"How might cerebrotendinous xanthomatosis be treated?","answerText":"Cerebrotendinous xanthomatosis may be treated with chenodeoxycholic acid (CDCA), which has been shown to normalize levels of cholestonal and improve neurologic symptoms. Inhibitors of HMG-CoA reductase may be used&nbsp;alone or in combination with CDCA. They&nbsp;are also effective in decreasing cholestanol concentration and improving clinical symptoms, however&nbsp;these treatments can lead to muscle damage. Coenzyme Q10 may improve muscle weakness, and cataract surgery may also be required.[503]","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12859,"relatedDiseaseName":"Autosomal Recessive Cerebellar Ataxias","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":6895,"relatedDiseaseName":"Leukodystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":21790,"abbreviatedInquiry":"I believe my daughter may have cerebrotendinous xanthomatosis. Can you provide me with more information on this condition?","caseQuestions":[{"questionId":775,"questionText":"What is cerebrotendinous xanthomatosis?","answerText":"<strong>Cerebrotendinous xanthomatosis</strong> is a&nbsp;disorder characterized by abnormal storage of fats (lipids) in many areas of the body (<a href=\"http://www.ninds.nih.gov/disorders/lipid_storage_diseases/lipid_storage_diseases.htm\" target=\"_blank\">lipid storage disease</a>).[503] People with this disorder cannot break down certain lipids effectively (such as&nbsp;cholesterol), so these fats form fatty yellow nodules called xanthomas, that accumulate in the body,&nbsp;especially&nbsp;in the brain and the tendons that attach muscle to bone, which is reflected in the condition name (cerebro- meaning brain and -tendinous referring to tendons). Symptoms may include diarrhea, clouding of the lens of the eyes (cataracts), tendon problems and&nbsp;progressive neurologic problems, such as epilepsy, movement disorders, impaired speech (dysarthria), loss of sensation in the arms and legs (peripheral neuropathy), dementia, hallucinations, and depression. Other symptoms may include brittle bones that are prone to fracture (<a title=\"Show picture\" class=\"img-popup\" href=\"https://ghr.nlm.nih.gov/art/large/bone-with-osteoporosis.jpeg?ow\" data-footer=\"Credit: Tefi/Shutterstock.com\" data-remote=\"/art/large/bone-with-osteoporosis.jpeg\" data-alt=\"The inside of normal bone versus bone with osteoporosis. The bone with osteoporosis has larger empty spaces in the tissue.\" data-toggle=\"lightbox\" data-title=\"Osteoporosis\"><span class=\"nobreak\">osteoporosis<span title=\"Picture\"></span></span></a>) and an increased risk of developing heart or lung failure because of lipid buildup.[13737][503] It is caused by mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/CYP27A1\" target=\"_blank\">CYP27A1</a> </em>gene. Treatment may involve chenodeoxycholic acid (CDCA), inhibitors of HMG-CoA reductase, coenzyme Q<sub>10</sub> and surgery to remove cataracts.[503]<br />\r\n<br />\r\n<br />","dateModified":"2017-08-23T00:00:00","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13737,"authors":"","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cerebrotendinous-xanthomatosis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":776,"questionText":"What are the signs and symptoms of cerebrotendinous xanthomatosis?","answerText":"The symptoms seen in cerebrotendinous xanthomatosis are listed below. We have also included the typical age when each symptom appears.[503]\r\n<ul>\r\n    <li>Chronic diarrhea (infancy)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/cataract.html\" target=\"_blank\">Cataracts</a> (early childhood)\r\n    </li>\r\n    <li>Mental impairment (infancy or at puberty)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001447.htm\" target=\"_blank\">Xanthomas</a> (adolescents to early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/dementia.html\" target=\"_blank\">Dementia</a> with slow deterioration in intellectual abilities (early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.ninds.nih.gov/disorders/spasticity/spasticity.htm\" target=\"_blank\">Spasticity</a> (early adulthood)\r\n    </li>\r\n    <li>Cerebellar signs such as <a href=\"http://www.nlm.nih.gov/medlineplus/tremor.html\" target=\"_blank\">intention tremor</a>, difficulty with fast hand movements, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003037.htm\" target=\"_blank\">nystagmus</a>, truncal <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=ataxia\" target=\"_blank\">ataxia</a>, and <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm\" target=\"_blank\">rhomberg's sign</a>) (early adulthood)\r\n    </li>\r\n    <li>Behavioral changes (early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003258.htm\" target=\"_blank\">Hallucinations</a> (early adulthood)\r\n    </li>\r\n    <li>Agitation (early adulthood)\r\n    </li>\r\n    <li>Aggression (early adulthood)\r\n    </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/depression.html\" target=\"_blank\">Depression</a> (early adulthood)\r\n    </li>\r\n    <li>Suicide attempt (early adulthood)</li>\r\n</ul>\r\n<p>Other symptoms may include <a href=\"http://www.nlm.nih.gov/medlineplus/dystonia.html\" target=\"_blank\" style=\"font-size: 12pt;\">dystonia</a><span style=\"font-size: 12pt;\">, atypical parkinsonism, </span><a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=\"_blank\" style=\"font-size: 12pt;\">seizures</a><span style=\"font-size: 12pt;\">, and </span><a href=\"http://www.nlm.nih.gov/medlineplus/peripheralnervedisorders.html\" target=\"_blank\" style=\"font-size: 12pt;\">peripheral neuropathy</a><span style=\"font-size: 12pt;\">.</span></p>","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":777,"questionText":"Where do the xanthomas typically occur?","answerText":"The xanthomas commonly occur on the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19089.htm\" target=_blank>tendons</a>, such as the Achilles tendon&nbsp;and the tendons of the elbows, hands, knees, and neck. Xanthomas have also been reported in the lungs, bones, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002311.htm\" target=_blank>central nervous system</a>.[503]","dateModified":"2013-09-12T16:31:00","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":779,"questionText":"What causes cerebrotendinous xanthomatosis?","answerText":"Cerebrotendinous xanthomatosis is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene/CYP27A1\" target=\"_blank\"><em>CYP27A1 </em>gene</a>.[503]","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":780,"questionText":"Is genetic testing available for cerebrotendinous xanthomatosis?","answerText":"Yes, testing of the <i>CYP27A1 </i>gene is available. The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/conditions/C0238052/\" target=_blank>Genetic Testing Registry</a> provides information on clinical and research tests available for this condition.","dateModified":"2013-09-12T16:53:00","resourceClassificationName":"Diagnosis","references":[]},{"questionId":778,"questionText":"How is cerebrotendinous xanthomatosis diagnosed?","answerText":"Cerebrotendinous xanthomatosis is diagnosed by a combination of clinical features,&nbsp;cholestanol levels, and genetic testing. People with cerebrotendinous xanthomatosis have high levels of cholestanol in their blood. Genetic testing of the CYP27A1 gene is also available and can detect mutations in about 98% of patients.[503]","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":781,"questionText":"How might cerebrotendinous xanthomatosis be treated?","answerText":"Cerebrotendinous xanthomatosis may be treated with chenodeoxycholic acid (CDCA), which has been shown to normalize levels of cholestonal and improve neurologic symptoms. Inhibitors of HMG-CoA reductase may be used&nbsp;alone or in combination with CDCA. They&nbsp;are also effective in decreasing cholestanol concentration and improving clinical symptoms, however&nbsp;these treatments can lead to muscle damage. Coenzyme Q10 may improve muscle weakness, and cataract surgery may also be required.[503]","dateModified":"2017-08-23T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":503,"authors":"Federico A, Dotti MT, Gallus GN","articleTitle":"Cerebrotendinous Xanthomatosis","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5613,"phenoTypeName":"Abnormality of vision","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3027,"phenoTypeName":"Xanthelasma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8521,"phenoTypeName":"Abnormal pyramidal sign","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13705,"phenoTypeName":"Abnormality of extrapyramidal motor function","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14305,"phenoTypeName":"Abnormality of the periventricular white matter","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9006,"phenoTypeName":"Angina pectoris","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13787,"phenoTypeName":"Atherosclerosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6011,"phenoTypeName":"Depressivity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14131,"phenoTypeName":"Hallucinations","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14568,"phenoTypeName":"Hypercholesterolemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8988,"phenoTypeName":"Myocardial infarction","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13842,"phenoTypeName":"Neurological speech impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14302,"phenoTypeName":"Cerebral calcification","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5691,"phenoTypeName":"Cholestasis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5673,"phenoTypeName":"Joint dislocation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5683,"phenoTypeName":"Joint stiffness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13413,"phenoTypeName":"Malabsorption","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14159,"phenoTypeName":"Nephrolithiasis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14555,"phenoTypeName":"Abnormal circulating cholesterol concentration","percentRanges":"-"},{"phenoTypeId":11188,"phenoTypeName":"Abnormality of central somatosensory evoked potentials","percentRanges":"-"},{"phenoTypeId":255,"phenoTypeName":"Abnormality of the dentate nucleus","percentRanges":"-"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","percentRanges":"-"},{"phenoTypeId":13447,"phenoTypeName":"Cerebral atrophy","percentRanges":"-"},{"phenoTypeId":9344,"phenoTypeName":"Cholelithiasis","percentRanges":"-"},{"phenoTypeId":13990,"phenoTypeName":"Delusions","percentRanges":"-"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","percentRanges":"-"},{"phenoTypeId":5113,"phenoTypeName":"EEG with generalized slow activity","percentRanges":"-"},{"phenoTypeId":13590,"phenoTypeName":"EMG: axonal abnormality","percentRanges":"-"},{"phenoTypeId":5651,"phenoTypeName":"Optic disc pallor","percentRanges":"-"},{"phenoTypeId":10268,"phenoTypeName":"Osteoporosis","percentRanges":"-"},{"phenoTypeId":4485,"phenoTypeName":"Pseudobulbar paralysis","percentRanges":"-"},{"phenoTypeId":13725,"phenoTypeName":"Respiratory insufficiency","percentRanges":"-"},{"phenoTypeId":5138,"phenoTypeName":"Tendon xanthomatosis","percentRanges":"-"},{"phenoTypeId":6393,"phenoTypeName":"Tuberous xanthoma","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Cerebrotendinous_xanthomatosis"}